Immediate Impact
1 from Science/Nature 64 standout
Citing Papers
Abelacimab versus Rivaroxaban in Patients with Atrial Fibrillation
2025 Standout
Cardiac Rehabilitation — Challenges, Advances, and the Road Ahead
2024 Standout
Works of Prem Pais being referenced
Apixaban in Comparison With Warfarin in Patients With Atrial Fibrillation and Valvular Heart Disease
2015
Rationale and design of AVERROES: Apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment
2010
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Prem Pais | 846 | 97 | 280 | 116 | 20 | 946 | |
| Eivind Berge | 830 | 99 | 214 | 213 | 35 | 1.0k | |
| José María Lobos | 693 | 134 | 154 | 67 | 43 | 875 | |
| Mikhail Ruda | 989 | 223 | 389 | 51 | 13 | 1.1k | |
| Meytal Avgil Tsadok | 808 | 50 | 201 | 171 | 45 | 1.0k | |
| A G Fennerty | 391 | 160 | 497 | 114 | 29 | 1.1k | |
| Frits R. Rosendaal | 666 | 123 | 341 | 185 | 13 | 855 | |
| Lynn B. Oertel | 957 | 126 | 307 | 93 | 11 | 1.1k | |
| Susan R. Heckbert | 412 | 198 | 210 | 161 | 23 | 920 | |
| Emad Abu-Assi | 580 | 145 | 44 | 88 | 47 | 787 | |
| Mette Hurlen | 881 | 206 | 392 | 97 | 18 | 1.0k |
All Works
Loading papers...